Bioretec wins FDA 510(k) clearance for ActivaScrew Cannulated COM implant

• Bioretec won FDA 510(k) clearance for its ActivaScrew Cannulated COM bioresorbable compression screw.
• The decision enables US commercialization in cleared indications, supporting expansion in the world’s largest orthopedic implant market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioretec Oyj published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.